Watchlist Price Alert

BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

98.74

-0.33 (-0.33%)

At close: May 23, 2025, 3:59 PM

98.68

-0.06%

After-hours: May 23, 2025, 05:21 PM EDT

BioNTech SE Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	2.75B	3.82B	17.31B	18.98B	482.3M	108.59M	127.58M	61.6M
Cost of Revenue	541.3M	599.8M	3B	2.91B	59.3M	243.83M	156.73M	94.81M
Gross Profit	2.21B	3.22B	14.32B	16.07B	423M	-135.24M	-29.16M	-33.22M
Operating Income	-1.31B	690.4M	12.64B	15.28B	-82.4M	-181.52M	-53.85M	-61.28M
Interest Income	437.6M	350.27M	48.5M	1.5M	n/a	1.78M	2M	2.13M
Pretax Income	-677.7M	1.19B	12.95B	15.05B	-145.8M	-179.44M	-47.66M	-85.91M
Net Income	-665.3M	930.3M	9.43B	10.29B	15.2M	-179.17M	-48.02M	-85.65M
Selling & General & Admin	599M	557.7M	541.2M	327.2M	108.56M	43.41M	27.09M	29.49M
Research & Development	2.25B	1.78B	1.54B	949.2M	645M	226.47M	143.04M	85.5M
Other Expenses	670.9M	188M	-408.3M	-495M	-248.1M	-223.6M	-145.43M	-86.93M
Operating Expenses	3.52B	2.53B	1.67B	781.4M	505.4M	46.28M	24.7M	28.06M
Interest Expense	12.6M	569.94K	18.9M	5.4M	2M	1.72M	1.72M	676K
Selling & Marketing Expenses	67.9M	62.7M	59.5M	50.4M	12.9M	2.72M	3.04M	6.6M
Cost & Expenses	4.07B	3.13B	4.67B	3.69B	564.7M	290.11M	181.43M	122.88M
Income Tax Expense	-12.4M	255.8M	3.52B	4.75B	-161M	-268K	600K	45K
Shares Outstanding (Basic)	240.18M	240.6M	243.3M	244M	253.3M	211.5M	226.86M	226.86M
Shares Outstanding (Diluted)	240.18M	242.7M	249.8M	259.7M	253.3M	211.5M	226.86M	226.86M
EPS (Basic)	-2.77	3.87	38.78	42.18	0.06	-0.85	-0.21	-0.38
EPS (Diluted)	-2.77	3.83	37.77	39.63	0.06	-0.85	-0.21	-0.38
EBITDA	-367.1M	1.38B	12.86B	15B	-105.1M	-143.41M	-24.64M	-70.13M
EBIT	-665.1M	1.19B	12.74B	14.93B	-133.99M	-177.7M	-47.33M	-79.98M
Depreciation & Amortization	298M	183.4M	123.3M	78.2M	36.1M	33.8M	22.69M	9.85M